Analysts at Wedbush raised their Q4 2024 earnings estimates for Fennec Pharmaceuticals in a research note issued to investors ...
MannKind Corp (MNKD) stock saw a decline, ending the day at $6.74 which represents a decrease of $-0.28 or -3.99% from the prior close of $7.02. The stock opened at $7.02 and touched a low of $6.72 ...
End-of-year deals, along with replacement of vehicles lost to hurricanes and anticipation of higher prices in 2025, may be ...
Hosted on MSN18h
3 AI Stocks That Could Each Be Worth $4 Trillion in 2025The artificial intelligence (AI) industry is growing faster than ever, with top tech companies making AI a big part of their ...
Analysts at Wedbush lifted their FY2027 EPS estimates for shares of Neurocrine Biosciences in a report released on Monday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback